Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good grief. Has anyone on here run or grown a small business before???
This business launched basically in Feb. They hand made patches and roll-ons until they could afford to go to mass production. Now that mass production has happened, the plan is to sign up distributors, attack the VA, pursue Amazon, continue to sell online, etc...
These things dont turn to gold overnight. The expectations around here are atmospheric.
If half as many tweets got sent out, about this company and their quality product, as posts on here concerning this company's lack of PRs, Amazon tribes that have been cut off from civilization for decades might know about PBPMS.
It was a nice and refreshing break... from thinking about BIEI I mean...
Fish, things are great. On behalf of SE Texas, thank you for what you did. The most amazing thing about this entire disaster has been how many boats/jet skis/atvs showed up to Houston to help rescue and ferry people out of their homes to shelters. It was simply amazing.
Last couple of days we were focused on gathering supplies. My church became a temporary heliport for a team of R44 helicopters run by a bunch of rednecks. They delivered blood, meals and supplies. Currently, we are teamed up knocking out sheet rock and pulling out carpet in homes all throughout the community.
The heart and generosity of our fellow man are great; and Texans on the Gulf Coast saw that in abundance this week.
Fish be careful man. We've almost lost 2 dozen volunteers on the NW side in different kinds of boats trying to tangle with the currents. We cannot get to a whole neighborhood currently. Thank you for coming, all others, we could use your prayers.
Going silent for the next few days. Got a hurrican to fend off. For those that do, pray for us down here!
The anticipation of what could happen next week is killing me.
I'm not convinced that the VA is something that will happen this year. That is a government agency you are talking about. Everything has to go through the red tape that is government.
I would plan on the VA decision coming in 2018.
I do believe Amazon would happen before the VA though. My understanding of what is going on with Amazon is this, and it is largely my filling in details that I have not been given (speculation).
Contact with Amazon was made.
Amazon laid out relationship requirements.
BIEI is not able to meet those requirements.
BIEI has objectives to meet before relationship moves forward.
Amazon provides improvements to be made.
Mark your calendars for 40 days from yesterday. In the interview, it sounded like another interview was coming in 40 days. I wonder what is going to happen in 40 days...
They also removed the 'fill-in' pain patches that they used when they were having stock issues.
Opioid problems continue to make headlines. This is a great time to be a solution to the problem.
https://www.theguardian.com/society/2017/aug/16/drugs-opioid-overdose-teenagers-america-trump
My thoughts on today's interview and the opinions expressed since:
1. He has now made contact with Amazon, and the way forward is now clear. He has already learned something from the discussions with Amazon. You can see on the website that the products have all been changed to reflect "Hemp Oil" rather than "CBD".
I am interested in knowing what advertising on Amazon will mean for BIEI. Google and Amazon advertising in this space will be interesting.
2. Salesmen!!! This is perhaps the biggest step in my opinion because Hartman will no longer be going it alone.
I am interested in knowing how many, and what kind of experience and connections these salesmen have.
3. Volume production is available NEXT WEEK. This should be a game changer.
This is the moment I have been waiting for. Now it is make or break time. I want to see what they can do with volume in Q3-Q4; it will be very important to see the growth in sales.
4. Tony!!!!! LOL. I have my suspicions.
I remain confident that we will see more improvements to come. In terms of improvements, at my company, we strive to find 1% improvements, all the time. If you can find 1 or 2 per month, they are additive and provide you with 12-24% improvement on the year! The salesmen is a huge improvement, the volume production is a huge improvement, the keyword optimizing is a 1% improvement. This will pay off.
Sorry, I have been focused on my home remodel last week and this week. I will try to pay it some attention this week. There was some exchange of information but not enough for a complete picture yet.
I dont have the number to the company red line. It's a back and forth process to ask information in pieces and then put it all together.
I'm aiming to find out.
I forwarded the company 2 things in regard to Amazon last night.
1. My contacts (phones & email) from my discussions with Amazon from my personal business.
2. Recommended process by which BIEI should start with Amazon, as recommended to my by a contact that is an Ops Manager with Amazon.
Let me see what I can do.
I have confirmed the materials have arrived.
Start the clock.
FYI, all indications are that trial runs have been on-going, and is what is currently available for sale on the website.
Also, from what I have been told, First production(THOUSANDS!) could be available as early as next week.
It all depends on when the foam material showed up from 3M. I have not been able to confirm it's arrival as of yet.
I'll remind you that once the patches are available, the game changes and new plans for sales, marketing and distribution take effect.
Materials and Tooling that was on order was scheduled to arrive "on or about" August 4 (Today).
First production could be available as early as Aug 15.
We are close.
Have you been expecting something over the last few weeks? I have clearly laid out what the company shared, which was that nothing was going to happen until the volume production was wrapping up/complete. The 13 points looks to be a glimpse into it.
What will say when production volumes are declared and sales/marketing/distributor signup campaigns begin?
BIEI announces modification of funding structure
El Paso, Texas, July 27, 2017 – On July 24, 2017 Premier Biomedical, Inc. (OTCQB: “BIEI“) withdrew its registration statement on Form S-1 in order to modify its funding structure. The equity funding underlying this registration was announced in the April CEO Update Letter.
William A. Hartman, President and CEO of Premier Biomedical stated, “Corporate finance for smaller public companies is complicated and ever-changing. The SEC required revised wording of the funding structure. We work closely with our funding partners, and the rules required that we withdraw the S-1 in order to make agreed-upon changes. We anticipate re-filing in a short period of time.”
For more information please contact:
William A. Hartman
President and CEO
(724) 633-7033
w.hartman@premierbiomedical.com
www.premierbiomedical.com/
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (OTCQB: BIEI) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. Premier has obtained, via exclusive license agreements, the technology behind three granted US Patents, multiple pending provisional patents, and a PCT Europe National Patent. Founded in 2010, Premier has partnered with the University of Texas at El Paso (UTEP). The company’s R&D efforts are centered in El Paso, TX, and their business offices are in Western Pennsylvania. The Company is a fully-reporting issuer whose common stock trades on the OTCQB marketplace maintained by OTC Markets Group, Inc. under the ticker symbol “BIEI.” For more information please visit our website: http://www.premierbiomedical.com/.
http://www.premierbiomedical.com/premier-biomedical-announces-modification-of-funding-structure/
I havent seen any movement since the interview, but without a PR, we arent gonna.
Biggest news is that we find out a LOT more after volume production is complete and new sales, marketing and distribution plans go live; and we are almost there.
Best news today is that we have plenty of inventory for now.
I'm definitely bullish on this. As I mentioned in my post #45533, once volume production happens, the game changes. The 13 point plan goes full tilt. There is a lot of sales, marketing and distribution in those 13 points. #4, 6, 7, 8, 12 IMO decide the fate of the company, and based on #9, I believe it will be a success.
Company said to expect a public statement on the recent withdrawal in the near future. Would not share any details.
I'm personally expecting it in 3-5 business days.
Haven't heard anything on this. Company was trying to distance themselves from Isodiol last I checked.
It sounds like the trial production runs.
Part of what the patches are made out of... I believe it's the adhesive foam type. The foam required a minimum order and carried a need for volume production. From my understanding, all other pieces of the puzzle are standing by.
We are waiting on the foam to come in, which the company said the promised date was first week of August. I still believe we are looking at Mid-August before the marketing campaign and production hit full force. Hope you guys can stomach another 3-4 weeks of this, it should be worth it!
The company has confirmed that the missing piece for production has not arrived yet. The company is still working through trials with limited materials available. The company stated that the material is not due in until the first couple of weeks of August.
To me this means we wont see big news or movement this month, but that is just my opinion. I will be here through the volume production news. The marketing, sales and distribution efforts will follow. I'm a 'long' as long as I keep seeing the progress. Realistically, I think that means that I am solidly here through Q3 financials, so that I can see the plan unfold and the revenue grow. I will re-assess in October and along the way as news comes out, but I am firmly committed until something scares me.
Could be a fun week... Hartman led off the week with a CEO letter. How often does he come out swinging on Monday before open???
Still not sure how I feel about Amazon relationship, but the talk about expanding distribution throughout North America is enough to get me excited.
PREMIER BIOMEDICAL, INC. CEO LETTER – July, 2017
Posted at July 17, 2017 | By : Admin | Categories : Investor News,Investor Relations,News,Press Releases,Publicity,Uncategorized | 0 Comment
Greetings From The CEO and Staff at Premier Biomedical!
This past quarter has been a very busy and eventful one for Premier Biomedical.
Finance and Stock Performance
• Late in the first quarter, we entered into an equity financing deal that can potentially bring over $7 million of capital into the company over the next three years, contingent upon favorable stock price appreciation. Details of this financing were contained in a previous press release and 8K filing.
• The resulting capital infusion allowed us to ramp up our pain management products pre-production builds and search for suitable production sources.
• We have dissolved the Pain Management Products joint venture and have integrated the Hemp Oil Products Pain Management Business into PBI. Our issued patent on our medication whose primary ingredients are most widely used to treat chemical and alcohol addiction fit well in our pain product division focus. This is a real synergy between our patented drug and our hemp-based formulations and enables us to focus more attention on the entire pain management business.
• These pain products will be installed into a Pain Management Division, while our anti-cancer developments will be in a separate Biologics Division.
• We consider our stock to be artificially low and a good investment for the future.
Immunotherapy and Biologics.
• Continuing discussions with several potential suitors to evaluate how we might jointly proceed to develop our proprietary technology to a point where it will be market ready.
Pain Management.
• Many of our stockholders and followers have asked about the status of our distributor agreement with the nation’s largest on-line pharmacy. We had indicated earlier that we expected the agreement to be signed several months ago, but that has not happened due to a number of issues, including two complete changes in top management at that company, to issues related to perceived sales and marketing restrictions. We have continued working with them and have not let frustration with corporate decision making stop us. We still remain hopeful and cautiously optimistic, but cannot guarantee the results. If we are unable to conclude this distributorship deal, we will seek arrangements with other large scale distributors.
• In the last days of April, we experienced a spike in orders for our products, which was both good news and bad. Volume production was not yet ready, and pre-production hand assembly processes were unable to keep up with the demand. As a result, customers experienced out-of-stock conditions and excessive delays in receiving products.
• We did what we could to mitigate the inventory shortages and arranged for a spot buy of another product to provide us with synthetic enhanced products to provide both immediate and long term pain relief for our customers. These products have been met with mixed reviews – some customers love them and have reordered them; others do not. On that basis, we will continue those products in demand and discontinue those with limited sales potential.
• In our efforts to launch production on our original patch and roll-on, we have become more acutely aware of market trends, market needs and market gaps. As a result, we have delayed our exploration into a range of different hemp oil-based products, like edibles and sprays, in favor of expansion of patch products. We believe the pain patch market is an underserved segment of the pain management market, and holds great potential for growth.
• We will be developing additional sizes and shapes of our hypoallergenic foam patch. These will range from small bandage-sized one-day patches ideal for short term local pain, to large area patches for wide spread, longer term pain. We will also continue to offer both a sage-scented, oil based roll-on and a lavender water based formulation roll-on.
• We are also increasing the levels of active pain reducing ingredient in our patches and roll-ons. These new patches, which have recently become available, contain 50 mg of hemp oil extracts, which is the most in the industry to our knowledge. Our oil based roll-on will increase its hemp oil extract content by more than 35% to 150mg, also the most in the industry to our knowledge.
• To date, we have made all of our topical pain patches and roll-on applicators via hand operations. We simply could not expand our distributorships nor plan for the future until we had resolved our formulations and had developed a reliable volume manufacturer.
• Now that we have resolved the difficult volume manufacturing problem, we will aggressively expand our distribution network. We intend to utilize the very successful relationships we have developed with Rx Xpress, a pharmacy, and Dr Vinton’s Pain Clinic, both in Grove City, PA as a template to expand to other cities throughout the US, Canada, Mexico and the rest of the world.
• We intend to work with Amazon to further expand the sales through our web site at: painreliefmeds.com as well as from our direct distributors.
• A potential European distributor has contacted us to investigate the possibility of a drop-ship agreement. We are still working with them to resolve all issues. We intend to attempt to develop other off-shore distributors as our business expands.
• We have been working with the Chronic Illness Bloggers, a worldwide group to request them to evaluate the effectiveness of our products to relieve pain. We have had a number of very positive evaluations to date and have included these evaluations in the many voluntary testimonies we have received to date since we went into this business February 1, 2017. We expect more positive evaluations of our current products from this group and will utilize their excellent services to evaluate each new product we develop.
• Many of the voluntary testimonies that we have received to date indicate that the users of our products were able to achieve true pain relief and stop the use of dangerous opioid painkillers. Since we have seen estimates that opioid-related deaths now exceed the death rate from automobile accidents, we believe that the time is right to petition the national and state agencies to evaluate our all-natural, pesticide-and-solvent-free products as a recommended alternative to opioid-based dangerous prescription pain pills which often lead to heroin addiction and death.
• We are working with the Veterans Administration (VA) to secure their endorsement to use our topical pain relief products in lieu of opioid pain products in their hospitals. We have prepared a presentation and are starting our process with VA personnel. Our plan is to take our proposal to the national level as soon as possible via our established contacts.
Investor/Public Relations Programs.
• In an effort to broaden our product exposure and boost our pain product sales, we have an Investor Relations firm promoting our company and products on social media. We are expanding our social media marketing campaigns, including Facebook, focusing on the 50+ age demographic, which past experience has indicated is our prime market.
• I plan to continue promoting Premier Biomedical, and providing updates on our progress through Uptick Newswire press releases, and monthly radio broadcasts, which have been very effective in the past. This is in addition to the occasional Stu Taylor radio show interviews.
Summary.
• This first half, we cleared our books of convertible debt, launched a revenue-generating product line, and secured more conventional financing with incentives for the lender to appreciate, rather than depreciate our stock price.
• We established a number of direct distributors, including pharmacies and health clinics.
• Now that we have resolved the product formulations and volume manufacturing to our specifications, we are attempting to expand our distributor networks both within North America as well as off-shore.
• We are in the process of developing, and launching several additional pain relieving products which we intend to spot-market test.
We have been very busy building our business, and now that we have resolved the basic issue of developing an industry-best formulation and a volume manufacturing system, we are poised to expand our business geometrically. We thank our loyal stockholders and pledge that we will continue our efforts on their behalf. We thank you for your continued support.
Sincerely,
William A. Hartman
President and CEO
Premier Biomedical Inc.
(724) 633-7033
PR@premierbiomedical.com
http://www.premierbiomedical.com/
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
http://www.premierbiomedical.com/premier-biomedical-inc-ceo-letter-july-2017/
We are getting close. The material needed has not arrived yet tho. Company confirmed it has not.
You are right about it being a PR for them, but it is keeping our name out there. I'm in favor of that. Hartman said that it would be a flurry of PRs once the production pieces are in place. If this is the trickle start, I'm good with that.
This is becoming steady PR...
This news is not nearly as big of a news item as production manufacturing being complete, distributors being signed, VA endorsement of the product, Medicare covering the patches, overseas distribution, etc...
Yes this is good news, but the big fish are still out there to reel in.
Yeah, it was in the 13 Point Plant from the interview... here is a recap:
13 Points in Interview:
1. Closed Joint Venture, BIEI fully owns PBPMS [See point 2].
2. Pain Management Products will fall under Pain Management Division, Cancer will be under Biologics division.
3. Were making everything by hand to date, moving to volume manufacture by formulations.
4. Aggressively expanding distribution network now that there is volume manufacturing in place.
5. Working with Chronic Illness Bloggers to attain reviews.
6. Initiated contact with Amazon for sales.
7. Pharmacy by mail distributor is hopeful, but have
8. European distributor showing interest for drop-ship.
9. Testimonies of decreasing opiod use due to products.
10. Planning on expanding pain patch size offerings to day patches etc.
11. Petition insurance agencies and medicare to cover these products in replacement of opiods.
12. Working with VA for pain patch endorsement.
13. Considering buyback of stock, in order to increase value to existing shareholders.
PBPMS keeps 100% of profits?